Family-Based Treatment for Childhood Obesity
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how a new family-based approach to managing childhood obesity affects children's body mass index (BMI) over 18 months. Participants will split into two groups: one will follow a standard family-based behavioral treatment (FBT) plan, while the other will focus additionally on reducing the variety of high-energy-dense foods consumed (FBT+Variety). Researchers will assess changes in dietary habits, activity levels, and weight. This trial suits children aged 8 to 12 who are above the 85th percentile for BMI and have an adult caregiver willing to participate. As an unphased trial, this study allows families to contribute to innovative research that could shape future obesity treatments.
Do I need to stop my current medications to join the trial?
The trial does not specify if you need to stop taking your current medications. However, if you are using prescription medications that could limit exercise, you will need written consent from a physician to participate.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research has shown that family-based treatments (FBT) for childhood obesity are generally safe. In various studies, children in these programs achieved better weight outcomes without major side effects. This includes both regular FBT and a version that limits food variety, known as FBT+Variety.
For FBT, evidence indicates that children lost weight over time, with no serious negative effects reported. This method is well-accepted and helps families make healthy lifestyle changes together.
The FBT+Variety approach, which reduces the variety of high-calorie foods, also appears safe. One study found that children in this group lost more weight without any reports of harm.
Overall, these treatments focus on changing behavior and diet, which are non-invasive and considered safe for children.12345Why are researchers excited about this trial?
Researchers are excited about these treatments for childhood obesity because they offer a family-centered approach that emphasizes behavioral changes rather than relying solely on medication or surgery. The FBT (Family-Based Treatment) uses a Traffic Light Diet that simplifies meal planning by categorizing foods into RED, YELLOW, and GREEN, making it easier for families to adopt healthier eating habits. The FBT+Variety treatment builds on this by helping families identify specific RED foods to limit, which can streamline decision-making and encourage consistency in dietary choices. Both methods also incorporate daily physical activity goals for both children and adults, making them holistic approaches to tackling obesity.
What evidence suggests that this trial's treatments could be effective for childhood obesity?
Research shows that family-based behavioral treatment (FBT) for childhood obesity works well. Studies indicate that children in FBT achieve better weight outcomes than those receiving standard care. Long-term data reveal that many children in FBT no longer have obesity after ten years.
In this trial, participants will join one of two treatment arms. One arm, the FBT+Variety approach, limits the variety of high-calorie foods and looks promising. Early studies found that this method led to greater reductions in child obesity levels compared to regular FBT. Overall, both treatments in this trial effectively manage childhood obesity by involving the family and making dietary changes.13467Who Is on the Research Team?
Hollie Raynor, PhD RD LDN
Principal Investigator
University of Tennessee Knoxville
Are You a Good Fit for This Trial?
This trial is for children aged 8-12 with a BMI over the 85th percentile and an adult caregiver in the household with a BMI over 25 kg/m2. Both must live together full-time, be able to walk two blocks without stopping, not have had or plan bariatric surgery within certain time frames, and not be pregnant or planning pregnancy.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive family-based behavioral obesity treatment (FBT) or FBT+Variety for 18 months, focusing on dietary intake, habituation, and physical activity
Follow-up
Participants are monitored for changes in BMI, dietary intake, and habituation after the treatment phase
What Are the Treatments Tested in This Trial?
Interventions
- FBT
- FBT+Variety
Find a Clinic Near You
Who Is Running the Clinical Trial?
The University of Tennessee, Knoxville
Lead Sponsor
The Miriam Hospital
Collaborator
University at Buffalo
Collaborator
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Collaborator
University of Memphis
Collaborator